-
Chan Zuckerberg Initiative Offers Funding, Engineering Help To Human Cell Atlas
Jun 1, 2017, 10:35 AM by Michael CroftBio-IT World News Brief | The Chan Zuckerberg Initiative (CZI) has announced financial support for the Human Cell Atlas, which is using sequencing technology to redefine every cell in the body. Funding and engineering support from CZI will enable EMBL-EBI, the Broad Institute, and the University of California Santa Cruz Genomics Institute (UCSC) to set up an open, cloud-based Data Coordination Platform to check, share, and analyze the vast amounts of diverse information generated.Full story -
Rommie Amaro on Curing Cancer at Exascale
Jun 1, 2017, 09:55 AM by Michael CroftBio-IT World | In her opening plenary keynote at the 2017 Bio-IT World Conference & Expo last week in Boston, Computing Cures: Discovery Through the Lens of a Computational Microscope, Rommie Amaro emphasized to attendees the direct correlation between advances in life-sciences IT and scientific discovery.Full story -
Genome editing Thats the way the CRISPR crumbles
Jun 1, 2017, 09:50 AM by Michael CroftNature Book Reviews | Nathaniel Comfort finds heroism but little nuance in Jennifer Doudna's account of her co-discovery.Full story -
Saint-Gobain Launches ValPlus™ Enhanced Validation Tubing Products for Bioprocessing Applications
Jun 1, 2017, 08:53 AM by Michael CroftSOLON, OH - Jun 1, 2017 - Saint-Gobains Life Science Business Unit, the trusted leader in Single-Use components and assemblies for bioprocessing, introduces another industry first capability for critical fluid applications: the ValPlus Family of tubing productsFull story -
SimpleTrials Selected for the Innovators Hub at DIA 2017
May 31, 2017, 16:45 PM by Michael CroftOAKLAND, CA - May 31, 2017 - SimpleTrials is the new Clinical Trial Management System (CTMS) released by Trial By Fire Solutions in 2016Full story -
TD2 and Deep 6 AI Announce Partnership to Accelerate Oncology Clinical Trial Recruitment
May 31, 2017, 13:19 PM by Michael Croft- May 31, 2017 - SCOTTSDALE, Ariz. & PASADENA, Calif.--Translational Drug Development (TD2) and Deep 6 AI announced today a formal agreement to work together in the fields of oncology and fibrosis to rapidly match eligible patients with appropriate clinical trialsFull story -
Johnson & Johnson Innovation, Edico, Illumina, Veeva Systems, And More: News From May 2017
May 31, 2017, 08:30 AM by Michael CroftFull storyBio-IT World Brief | News, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Johnson & Johnson Innovation, Edico, Illumina, Veeva Systems, and more.
-
Certara Partners with PUMC Hospital to Deliver PBPK Modeling and Simulation Support for Chinese Drug Development
May 31, 2017, 08:29 AM by Michael CroftPRINCETON, NJ - May 31, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it is partnering with Phase I Unit, Peking Union Medical College (PUMC) Hospitals Clinical Pharmacology Research Center (PUMCH-CPRC) in Beijing to help Chinese pharmaceutical companies enhance their drug development processesFull story -
MR Solutions brings preclinical MRI to World Preclinical Congress in Boston
May 31, 2017, 06:10 AM by Michael CroftGUILDFORD, UNITED KINGDOM - May 31, 2017 - MR Solutions, with offices in the UK and Boston, will be showing their latest state of the art 3T to 9Full story -
Recent Breakthroughs in the Fight Against Cancer – The New Revolution
May 30, 2017, 12:22 PM by Michael CroftMUNICH, GERMANY - May 30, 2017 - Definiens, a wholly-owned subsidiary of AstraZeneca, is the leader in Tissue Phenomics® and provider of solutions from biomarker discovery to meaningful diagnosticsFull story -
CRISPR Gene Editing Can Cause Hundreds of Unintended Mutations
May 30, 2017, 09:03 AM by Michael CroftPhys.org | As CRISPR-Cas9 starts to move into clinical trials, a new study published in Nature Methods has found that the gene-editing technology can introduce hundreds of unintended mutations into the genome.Full story -
Optibrium, Imperial College and DNDi Collaborate in Drug Development Programme for Neglected Diseases
May 30, 2017, 08:31 AM by Michael CroftCAMBRIDGE AND LONDON UK, AND GENEVA, SWITZERLAND - May 30, 2017 - Optibrium™, a developer of software for small molecule design and optimisation today announced it had entered into a collaboration with Imperial College London, the world leading science-based research institution and university, and Drugs for Neglected Diseases initiative (DNDi), a non-profit drug R&D organisation developing new treatments for neglected diseasesFull story -
Geneious Biologics to Power Better Biological Drug Development
May 29, 2017, 21:41 PM by Michael CroftAUCKLAND, NEW ZEALAND - May 23, 2017 - BIO-IT WORLD, BOSTON, MA – May 23, 2017 – Geneious Biologics, an enterprise software solution for screening antibodies and related constructs using sequence data, was launched today and will change the way scientists identify antibodies for use in biological drug developmentFull story -
Deloitte Debuts ConvergeHEALTH Evidence Lifecycle Management Solutions that Support Shift to Value Based, Personalized Health Care at 2017 Bio-IT World Conference
May 26, 2017, 13:34 PM by Michael CroftBOSTON, MA, UNITED STATES - May 23, 2017 - This year at the 2017 Bio-IT World Conference & Expo, Deloitte will be showcasing the latest updates to its ConvergeHEALTH suite of life sciences end-to-end evidence lifecycle management solutions, as well as hosting a series of panel discussions with life sciences innovatorsFull story -
Recipharm makes strategic appointment in the UK & Ireland
May 26, 2017, 08:55 AM by Michael Croft- May 26, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has invested in its UK & Ireland presence with the appointment of Shabbir Mostafa to its Business Management teamFull story -
RedLock Cloud Security Intelligence (CSI) team helps organizations avoid over $785 million in data breach costs
May 25, 2017, 18:55 PM by Michael CroftMENLO PARK, CA - May 25, 2017 - Menlo Park, CA (May 25, 2017) - RedLock, the true cloud infrastructure security company, today officially announced the RedLock Cloud Security Intelligence (CSI) team, which brings together elite security analysts, data scientists and data engineers from respected corporations such as Microsoft, Credit Suisse and HoneywellFull story -
Sartorius Stedim Biotech supports mainstream adoption of Quality by Design
May 25, 2017, 12:46 PM by Michael CroftGOETTINGEN, GERMANY - May 25, 2017 - Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has developed an innovative and fully integrated technology platform to meet the requirements of todays upstream bioprocessingFull story -
Thermo Fisher Scientific Strengthens Portfolio of Endotoxin-Free Plasmid DNA Isolation Kits
May 25, 2017, 11:26 AM by Michael CroftCARLSBAD, CA, UNITED STATES - May 15, 2017 - Thermo Fisher Scientific Inc., the world leader in serving science, has expanded its line of endotoxin-free plasmid DNA isolation products with the launch of the PureLink Expi Endotoxin-Free Maxi Plasmid Purification KitFull story -
Bio-IT World Announces 2017 Best Practices Awards Winners
May 25, 2017, 09:00 AM by Michael CroftFull storyBio-IT World | Bio-IT World has announced the winners of the 2017 Best Practices Awards at the Bio-IT World Conference and Expo. Entries from Maccabi Healthcare System, Rady Children’s Institute for Genomic Medicine, Allotrope Foundation, Earlham Institute, Biomedical Imaging Research Services Section (BIRSS), and Alexion Pharmaceuticals were honored.
-
Bio-IT World Announces 2017 Best Of Show Award Winners
May 24, 2017, 17:50 PM by Michael CroftFull storyBio-IT World | Bio-IT World announced the 2017 winners of the Best of Show Awards Program to a packed audience at the Bio-IT World Conference & Expo. The awards program recognizes the best of the innovative product solutions for the life sciences industry on display at the Bio-IT World conference in Boston.